NCT00839527 A Study to Determine the Safety and Efficacy of Albiglutide in Subjects With Type 2 Diabetes Status COMPLETED Phase PHASE3
NCT00839397 BRL29060A (Paroxetine Hydrochloride Hydrate) in Posttraumatic Stress Disorder Status COMPLETED Phase PHASE3
NCT00839254 Impact on Carriage, Acute Otitis Media, Immuno & Safety of GSK Biologicals' Pneumococcal Conjugate Vaccine 1024850A Status COMPLETED Phase PHASE3
NCT00838916 A Study to Determine the Safety and Efficacy of Albiglutide in Patients With Type 2 Diabetes Status COMPLETED Phase PHASE3
NCT00838903 Efficacy and Safety of Albiglutide in Treatment of Type 2 Diabetes Status COMPLETED Phase PHASE3
NCT00837213 Comparative Efficacy and Safety of Benzoyl Peroxide Used in Combination With Clindamycin vs. Benzoyl Peroxide Used in Combination With Clindamycin and Doxycycline in the Treatment of Moderate Acne Status COMPLETED Phase PHASE4
NCT00837044 Treximet in Acute Migraine Headache: Assessing Cognitive Function Status UNKNOWN Phase NA
NCT00835237 Evaluation of GlaxoSmithKline Biologicals' Boostrix® Vaccine in Comparison With Decavac™ Vaccine. Status COMPLETED Phase PHASE3
NCT00834457 A Pilot Study Of the Effects of Highly Active Antiretroviral Therapy on Kaposi's Sarcoma in Zimbabwe Status COMPLETED Phase PHASE2/PHASE3
NCT00833976 Omega-3 Fatty Acids (Lovaza) for Second Generation Antipsychotic-Associated Hypertriglyceridemia Status COMPLETED Phase PHASE4
NCT00833378 Drug Interaction Study Between Eltrombopag and Lopinavir/Ritonavir in Healthy Adult Subjects. Status COMPLETED Phase PHASE1
NCT00832364 Trial of an Injectable Biologic and U0279 as Combination Therapy for Severe Plaque-Type Psoriasis Status WITHDRAWN Phase PHASE4
NCT00831129 A Study for Pre-diabetic Patients With Cholesterol Lowering Drugs Status COMPLETED Phase PHASE2/PHASE3
NCT00829010 Primary and Booster Vaccination Study With a Pneumococcal Vaccine in HIV Infected, HIV Exposed Uninfected and HIV Uninfected Children 6 to 10 Weeks of Age. Status COMPLETED Phase PHASE3
NCT00828750 Clinical Evaluation of Eltrombopag in Chronic Idiopathic Thrombocytopenic Purpura (ITP) Status COMPLETED Phase PHASE3